Characteristics
|
No. of patients
|
Expression of miR-451
|
P value
|
---|
| |
Low, n (%)
|
High, n (%)
| |
---|
Age
| | | | |
≤ 45 yr
|
136
|
66 (47)
|
70 (50)
|
0.63
|
> 45 yr
|
144
|
74 (53)
|
70 (50)
| |
Sex
| | | | |
Male
|
206
|
100 (71)
|
106 (76)
|
0.42
|
Female
|
74
|
40 (29)
|
34 (24)
| |
WHO Type
| | | | |
I + II
|
11
|
4 (3)
|
7 (5)
|
0.36
|
III
|
269
|
136 (97)
|
133 (95)
| |
VCA-IgA
| | | | |
< 1:80
|
43
|
21 (15)
|
22 (16)
|
0.87
|
≥ 1:80
|
237
|
119 (85)
|
118 (84)
| |
EA-IgA
| | | | |
< 1:10
|
71
|
37 (26)
|
34 (24)
|
0.68
|
≥ 1:10
|
209
|
103 (74)
|
106 (76)
| |
T Stage
| | | | |
T1-T2
|
142
|
70 (50)
|
72 (51)
|
0.81
|
T3-T4
|
138
|
70 (50)
|
68 (49)
| |
N Stage
| | | | |
N0
|
42
|
89 (64)
|
85 (61)
|
0.62
|
N1-N3
|
238
|
51 (36)
|
55 (39)
| |
TNM Stage
| | | | |
I-II
|
91
|
49 (35)
|
42 (30)
|
0.37
|
III-IV
|
189
|
91 (65)
|
98 (70)
| |
- VCA-IgA: viral capsid antigen immunoglobulin A; EA-IgA: early antigen immunoglobulin A. All patients were restaged according to the 7th edition of the AJCC Cancer Staging Manual.